Correlation Between Caribou Biosciences and Unity Biotechnology
Can any of the company-specific risk be diversified away by investing in both Caribou Biosciences and Unity Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Caribou Biosciences and Unity Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Caribou Biosciences and Unity Biotechnology, you can compare the effects of market volatilities on Caribou Biosciences and Unity Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Caribou Biosciences with a short position of Unity Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Caribou Biosciences and Unity Biotechnology.
Diversification Opportunities for Caribou Biosciences and Unity Biotechnology
-0.31 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Caribou and Unity is -0.31. Overlapping area represents the amount of risk that can be diversified away by holding Caribou Biosciences and Unity Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Unity Biotechnology and Caribou Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Caribou Biosciences are associated (or correlated) with Unity Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Unity Biotechnology has no effect on the direction of Caribou Biosciences i.e., Caribou Biosciences and Unity Biotechnology go up and down completely randomly.
Pair Corralation between Caribou Biosciences and Unity Biotechnology
Given the investment horizon of 90 days Caribou Biosciences is expected to generate 0.52 times more return on investment than Unity Biotechnology. However, Caribou Biosciences is 1.93 times less risky than Unity Biotechnology. It trades about 0.12 of its potential returns per unit of risk. Unity Biotechnology is currently generating about -0.58 per unit of risk. If you would invest 160.00 in Caribou Biosciences on July 8, 2025 and sell it today you would earn a total of 67.00 from holding Caribou Biosciences or generate 41.88% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 4.69% |
Values | Daily Returns |
Caribou Biosciences vs. Unity Biotechnology
Performance |
Timeline |
Caribou Biosciences |
Unity Biotechnology |
Risk-Adjusted Performance
Weakest
Weak | Strong |
Caribou Biosciences and Unity Biotechnology Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Caribou Biosciences and Unity Biotechnology
The main advantage of trading using opposite Caribou Biosciences and Unity Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Caribou Biosciences position performs unexpectedly, Unity Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Unity Biotechnology will offset losses from the drop in Unity Biotechnology's long position.Caribou Biosciences vs. Intellia Therapeutics | Caribou Biosciences vs. Editas Medicine | Caribou Biosciences vs. Crispr Therapeutics AG | Caribou Biosciences vs. Beam Therapeutics |
Unity Biotechnology vs. Absci Corp | Unity Biotechnology vs. Precision BioSciences | Unity Biotechnology vs. Caribou Biosciences | Unity Biotechnology vs. ContraFect |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |